What Xttrium Laboratories does

Xttrium Laboratories is a family-owned, FDA-approved pharmaceutical manufacturer founded in 1932 and headquartered in Mt. Prospect, Illinois. The company specializes in Chlorhexidine Gluconate (CHG) formulations, producing a 0.12% prescription oral rinse, 2% and 4% topical antiseptic scrub solutions under the Dyna-Hex brand, and a 20% CHG solution used as an active pharmaceutical ingredient (API). The company also manufactures generic prescription oral solutions including Lactulose Solution, USP and Amantadine Hydrochloride Oral Solution. Its manufacturing operations are cGMP compliant, and Xttrium owns multiple FDA-approved New Drug Applications covering antiseptic claims including surgical hand scrub, healthcare personnel hand wash, skin wound cleansing, and patient pre-operative skin preparation.

The company's business model spans three revenue streams: branded antiseptic product sales (primarily through medical wholesalers, healthcare distributors, and 14+ major retail drug chains), private label and contract manufacturing services (offering label artwork, filling, packaging, testing, and shipping since 1984), and API supply (20% CHG solution sold across medical, dental, veterinary, cosmetic, and dairy industries). Go-to-market is exclusively direct B2B — no consumer-facing channels are operated. Xttrium's CHG oral rinse is reportedly dispensed by 90% of national and regional pharmacies, and the company manufactures over 150 branded and private label products in total.

Xttrium operates as a privately held, family-controlled enterprise with no disclosed external funding, no public listing, and no parent company. Its competitive position is anchored by regulatory approvals, decades-long relationships with retail pharmacy chains and wholesalers, and its status as the largest supplier of 20% USP Chlorhexidine Gluconate. The customer base is concentrated in U.S. healthcare providers, dental practices, pharmaceutical companies, and retail pharmacies, with no indication of international operations or geographic expansion.

Name

Xttrium Laboratories

Legal name

Xttrium Laboratories

Website

https://xttrium.com

Company type

Private

Founded year

1932

Operating status

Operating

Headcount range

51–100 employees

Short description

Xttrium Laboratories is a family-owned FDA-approved pharmaceutical manufacturer founded in 1932, specializing in Chlorhexidine Gluconate antiseptic products, generic prescription oral solutions, and contract manufacturing services for U.S. healthcare providers, wholesalers, and retail pharmacies.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Soap, Cleaning Compound, and Toilet Preparation Manufacturing (3256), Soap and Cleaning Compound Manufacturing (32561), Medical Equipment and Supplies Manufacturing (3391)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Hand Hygiene & Skin Antisepsis (Soaps, Sanitizers, Surgical Scrubs, CHG Prep) (HLAHANAE)

akta.pro secondary industries

Preservatives & Antimicrobials (Sorbates, Benzoates, Natamycin, Cultured Dextrose) (CRADAOAF), Unit-Dose & Compliance Packaging (Sachets, Strip Packs, Pill Organizers) (IMALAIAH)

Keywords

• Chlorhexidine gluconate manufacturing
• Topical antiseptic solutions
• Pharmaceutical contract manufacturing
• Generic oral rinse
• FDA-approved antiseptics

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Technology or R&D

Revenue model

1. Branded Antiseptic Products: Sale of branded Chlorhexidine Gluconate antiseptic products including oral rinse and scrub solutions to healthcare providers, pharmacies, and medical institutions
2. Private Label/Contract Manufacturing: Contract manufacturing services for branded and private label products, offering label artwork, filling, packaging, testing, and shipping capabilities for healthcare and retail partners
3. Active Pharmaceutical Ingredients (API): Supply of 20% Chlorhexidine Gluconate solution as an active pharmaceutical ingredient for use as a preservative and antibacterial/antiseptic agent across multiple industries

Go-to-market motion1 record

Distribution channels3 records

Marketing channels1 record

Core offering

Xttrium Laboratories manufactures Chlorhexidine Gluconate (CHG) antiseptic products at multiple concentrations, including 0.12% prescription oral rinse, 2% and 4% topical antiseptic scrub solutions (Dyna-Hex brand), and 20% CHG as an active pharmaceutical ingredient. The company also produces generic prescription oral solutions (Lactulose Solution, USP and Amantadine Hydrochloride Oral Solution). In addition, Xttrium offers full-service contract manufacturing for branded and private label partners, including label artwork, filling, packaging, testing, and shipping, from its FDA-approved, cGMP-compliant facility in Mt. Prospect, IL.

Product overview

Xttrium Laboratories is a family-owned FDA-approved manufacturer specializing in antiseptic products and generic prescription pharmaceuticals. The company operates as both a branded and private-label contract manufacturer, producing over 150 products. The core product portfolio centers on Chlorhexidine Gluconate (CHG) formulations at various concentrations: 0.12% oral rinse solution (prescription), 2% and 4% topical antiseptic solutions (Dyna-Hex brand), and 20% solution as an active pharmaceutical ingredient (API). The company also manufactures Lactulose Solution and Amantadine Hydrochloride Oral Solution as prescription generics. Manufacturing capabilities include label artwork, filling, packaging, testing, and shipping with cGMP compliant facilities in the Chicagoland area (Mt. Prospect, IL). The products serve healthcare, retail, dental, veterinary, cosmetic, and dairy industries through both branded and private label channels.

Differentiator

Problem solved

Functional benefit

Brands

• Dyna-Hex: Brand name for Chlorhexidine Gluconate antiseptic scrub solutions (2% and 4% concentrations) used for surgical hand scrub, healthcare personnel hand wash, and skin wound cleansing.

Products and services

• Dyna-Hex 2% (Chlorhexidine Gluconate 2% Topical Antiseptic Solution) Chlorhexidine Gluconate 2% topical antiseptic solution sold under the Dyna-Hex brand, used for surgical hand scrub, healthcare personnel hand wash, skin wound and general skin cleansing, and patient pre-operative skin preparation.
• Dyna-Hex 4% (Chlorhexidine Gluconate 4% Topical Antiseptic Solution) Chlorhexidine Gluconate 4% topical antiseptic solution sold under the Dyna-Hex brand, used for surgical hand scrub, healthcare personnel hand wash, skin wound and general skin cleansing, and patient pre-operative skin preparation.
• 0.12% Chlorhexidine Gluconate Oral Rinse Solution (Xttrium Brand Generic Rx) Prescription 0.12% Chlorhexidine Gluconate oral rinse solution used post oral surgery as an infection prevention product, available in unit dose, 4oz, and 16oz packaging sizes.
• 20% Chlorhexidine Gluconate Solution (API) 20% Chlorhexidine Gluconate solution supplied as an active pharmaceutical ingredient (API) for use as a preservative and antibacterial/antiseptic agent across medical, dental, veterinary, cosmetic, and dairy industries.
• Contract Manufacturing Services Full-service contract manufacturing for branded and private label partners, offering label artwork, filling, packaging, testing, and shipping using FDA-approved and cGMP-compliant facilities.
• Lactulose Solution, USP Lactulose Solution, USP for oral administration, manufactured as a generic prescription pharmaceutical.
• Amantadine Hydrochloride Oral Solution, USP Amantadine Hydrochloride Oral Solution, USP prescription medication manufactured as a generic pharmaceutical.

Quantifiable outcome

• 90% of national and regional pharmacies dispense Xttrium Brand Generic CHG Oral Rinse
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Three partnerships are on record, tiered core.

• Medical Wholesalers & DistributorscoreChannel Partner/ Reseller/ DistributorXttrium manufactures infection prevention products for many large-scale medical wholesalers and distributors, supplying branded and private label generic drug products nationwide.
• Healthcare & Pharmaceutical CompaniescoreStrategic or Co-development PartnerContract manufacturing partnerships with healthcare and pharmaceutical companies for CHG-based antiseptic products, utilizing FDA-approved and cGMP compliant facilities.
• Major Retail Drug ChainscoreChannel Partner/ Reseller/ DistributorXttrium supplies branded and private label generic drug products to over 14 major retail drug chains across the United States, with 90% of national and regional pharmacies dispensing their CHG Oral Rinse.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• PDI (Professional Disposables International): PDI manufactures chlorhexidine gluconate-based antiseptic products including skin preps, surgical scrubs, and CHG wipes sold to hospitals and dental practices. It is a direct competitor to Xttrium's Dyna-Hex CHG scrub portfolio across healthcare-acquired infection prevention use cases.
• Mölnlycke Health Care: Mölnlycke markets Hibiscrub and Hibitane, well-known CHG-based antiseptic solutions for surgical hand scrub, patient pre-operative skin preparation, and wound cleansing. It competes directly with Xttrium's 2%/4% Dyna-Hex and 20% USP CHG offering in healthcare channel sales.
• ANI Pharmaceuticals: ANI Pharmaceuticals is a U.S. specialty generics manufacturer operating a small set of cGMP facilities, producing oral solutions, injectables, and niche Rx products. It is a direct comparable to Xttrium's specialty oral Rx business (Lactulose, Amantadine) and private-label manufacturing model.
• X-GEN Pharmaceuticals: X-GEN is a privately held specialty pharmaceutical manufacturer developing, manufacturing, and distributing generic oral and topical Rx products. It mirrors Xttrium's model of owning ANDAs and serving both branded and private-label channels in dermatology, infectious disease, and adjacent categories.
• Cosette Pharmaceuticals: Cosette Pharmaceuticals is a U.S. specialty generics manufacturer producing prescription oral and topical dermatology products from FDA-inspected facilities, with a strong private-label and contract manufacturing orientation. It is directly comparable to Xttrium's branded + private-label + CDMO model serving pharmacy and institutional customers.

Broad incumbents

• Becton, Dickinson and Company (BD): BD offers the ChloraPrep and other CHG/isopropyl antiseptic skin preparation products through its BD Medical segment, alongside a much broader portfolio of medical devices, diagnostics, and biosciences. BD is a broad incumbent with overlapping CHG skin-prep claims and hospital sales infrastructure.
• 3M Health Care: 3M's Health Care division sells surgical skin antiseptics and CHG-based products alongside wound care, oral care, and drug delivery franchises. It is a broad incumbent whose CHG and antiseptic solutions compete with Xttrium's Dyna-Hex franchise while serving much larger end markets.
• Ecolab: Ecolab's Healthcare and Life Sciences businesses supply antiseptic products, hand hygiene solutions, and disinfectant formulations to hospitals and dental facilities. It overlaps with Xttrium on CHG and broader infection prevention use cases, though Ecolab is a much larger specialty chemicals and services conglomerate.
• STERIS: STERIS provides infection prevention and sterilization products, including surface disinfectants, instrument reprocessing, and certain antiseptic chemistries, sold to hospitals and life-science customers. It is a broad incumbent in healthcare infection prevention adjacent to Xttrium's CHG portfolio.
• Viatris: Viatris (formed via Mylan-Upjohn combination) is a large diversified global generics manufacturer with extensive oral solid and oral solution portfolios. It competes with Xttrium as a generic Rx supplier in categories such as chlorhexidine oral rinse and central nervous system oral solutions like amantadine and lactulose.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• Xx.com/Xttriumlabs

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Xttrium Laboratories